Literature DB >> 27997348

Relationship between plasma and salivary melatonin and cortisol investigated by LC-MS/MS.

Martijn van Faassen1, Rainer Bischoff1, Ido P Kema1.   

Abstract

BACKGROUND: Disturbance of the circadian rhythm has been associated with disease states, such as metabolic disorders, depression and cancer. Quantification of the circadian markers such as melatonin and cortisol critically depend on reliable and reproducible analytical methods. Previously, melatonin and cortisol were primarily analyzed separately, mainly using immunoassays.
METHODS: Here we describe the validation and application of a high-throughput liquid chromatography in combination with mass spectrometry (LC-MS/MS) method for the combined analysis of melatonin and cortisol in plasma and saliva. The LC-MS/MS method was validated according to international validation guidelines. We used this method to analyze total plasma, free plasma (as obtained by equilibrium dialysis) and saliva melatonin and cortisol in healthy adults.
RESULTS: Validation results for plasma and saliva melatonin and cortisol were well within the international validation criteria. We observed no difference between saliva collected by passive drooling or Salivette. Moreover, we noted a significant difference in saliva vs. free plasma melatonin. We observed on average 36% (95% CI: 4%-60%) higher salivary melatonin levels in comparison to free plasma melatonin, suggestive of local production of melatonin in the salivary glands.
CONCLUSIONS: The novel outcome of this study is probably due to the high precision of our LC-MS/MS assay. These outcomes illustrate the added value of accurate and sensitive mass spectrometry based methods for the quantification of neuroendocrine biomarkers.

Entities:  

Keywords:  cortisol; dialysis; liquid chromatography in combination with mass spectrometry (LC-MS/MS); melatonin; plasma; saliva

Mesh:

Substances:

Year:  2017        PMID: 27997348     DOI: 10.1515/cclm-2016-0817

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  Linking the non-visual effects of light exposure with occupational health.

Authors:  Luke L A Price; Ljiljana Udovičić; Thomas Behrens; Alwin van Drongelen; Anne Helene Garde; Koen Hogenelst; Marie Aarrebo Jensen; Marina Khazova; Kamila Nowak; Sylvia Rabstein; Erik Romanus; Agnieszka Wolska
Journal:  Int J Epidemiol       Date:  2019-10-01       Impact factor: 7.196

2.  A Sensitive and Specific Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Quantification of Salivary Melatonin and Cortisol: Development and Comparison With Immunoassays.

Authors:  Sunghwan Shin; Hyeonju Oh; Hea Ree Park; Eun Yeon Joo; Soo-Youn Lee
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

Review 3.  Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.

Authors:  Sébastien Lalanne; Claire Fougerou-Leurent; George M Anderson; Carmen M Schroder; Tali Nir; Sylvie Chokron; Richard Delorme; Bruno Claustrat; Eric Bellissant; Solenn Kermarrec; Patricia Franco; Laure Denis; Sylvie Tordjman
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

4.  Melatonin inhibits RANKL‑induced osteoclastogenesis through the miR‑882/Rev‑erbα axis in Raw264.7 cells.

Authors:  Yihao Tian; Zunlei Gong; Rui Zhao; Yue Zhu
Journal:  Int J Mol Med       Date:  2020-12-16       Impact factor: 4.101

Review 5.  Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals.

Authors:  Emmanuel Sunday Okeke; Martins Obinna Ogugofor; Ndidi Ethel Nkwoemeka; Ekene John Nweze; Charles Obinwanne Okoye
Journal:  Microbes Infect       Date:  2021-09-15       Impact factor: 2.700

6.  Spatially resolved sampling for untargeted metabolomics: A new tool for salivomics.

Authors:  Alessio Ciurli; Maximiliam Liebl; Rico J E Derks; Jacques J C Neefjes; Martin Giera
Journal:  iScience       Date:  2021-06-24

7.  Salivary melatonin in oral squamous cell carcinoma patients.

Authors:  Ivan Salarić; Ivana Karmelić; Jasna Lovrić; Ksenija Baždarić; Marko Rožman; Igor Čvrljević; Ivan Zajc; Davor Brajdić; Darko Macan
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

8.  Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients.

Authors:  Sandra Crnko; Markella I Printezi; Tijn P J Jansen; Laurynas Leiteris; Manon G van der Meer; Hilde Schutte; Martijn van Faassen; Bastiaan C du Pré; Nicolaas de Jonge; Folkert W Asselbergs; Carlo A J M Gaillard; Hans Kemperman; Pieter A Doevendans; Joost P G Sluijter; Linda W van Laake
Journal:  ESC Heart Fail       Date:  2020-03-31

9.  Melatonin Relations With Respiratory Quotient Weaken on Acute Exposure to High Altitude.

Authors:  Marcelo Tapia; Cristian Wulff-Zottele; Nicole De Gregorio; Morin Lang; Héctor Varela; María Josefa Serón-Ferré; Ennio A Vivaldi; Oscar F Araneda; Juan Silva-Urra; Hanns-Christian Gunga; Claus Behn
Journal:  Front Physiol       Date:  2018-06-29       Impact factor: 4.566

10.  Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.

Authors:  Amber Nous; Mandy Melissa Jane Wittens; Yannick Vermeiren; Peter Paul De Deyn; Christine Van Broeckhoven; Guy Nagels; Ilse Smolders; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.